% of paid up capital, Total investment 50 Millions baht. The acquisition of BS Myco Biotech shares will result in the BS Myco Biotech being a subsidiary of the Company. The Company signed the share
funds as stated in the prospectus. The Company’s first trading day was on 13 March 2019. However, the Company provided short-term loan with no interest rate and recorded as advance payment to Asia Capital
total financial cost for the year 2018 and 2017 amounted to Baht 1,102 million and Baht 995 million respectively, increase by Baht 107 million because of the increase of short-term loan for purpose of
, property, plant and equipment increased by Baht 76.42 million which was new machines that ordered since last year but the shipment delayed until the early of this year and there was some capital expenditure
166.43 million compared with last year mainly from short term loan for working capital and for purchasing plastic resin in cash to get cash discount. Moreover, the Company paid for dividend in May. As a
. Suppaluek Na Songkla, Mr. Ittidet Phonin and Miss Nittaya Na Songkla offered company to buy SUTG stock for 132,000 units whereas 66% of total paid-up capital of SUTG. Main reason of the deal is to come back
facility for accommodating increasing transactions in the short-term, the calculation of the capital to accommodate the digital https://www.sec.or.th/EN/Pages/News_Detail.aspx?SECID=8398 SEC public hearing
related parties in the capital market in order to create understanding and cooperation in the use of good governance principles for sustainable development.In this seminar, SEC was honored by Dr. Prasarn
and Exchange Act B.E. 2535 (1992) and Clause 5(1) in conjunction with Clause 7(1)(3) and (5), Clause 12(1) and (8), Clause 14 and Clause 25 of the Notification of the Capital Market Supervisory Board No
Act B.E. 2535 (1992) and Clause 5(1) in conjunction with Clause 7(1)(3) and (5), Clause 12(1) and (8), Clause 14 and Clause 25 of the Notification of the Capital Market Supervisory Board No. Tor Thor